Working to provide information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF)
Making promises for all our hearts
World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.
We’re supporting the Cardiovascular Health campaign with Media Planet UK
A Mother’s Mission to Educate the World About Arrhythmia
When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.
Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*
wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).
September Medical e-News 2018
BREAKING NEWS-Arrhythmia Alliance Grants to attend HRC2018 and much more.
Stroke prevention in Europe: how are 11 European countries progressing toward the European Society of Cardiology (ESC) recommendations?
Stroke is a leading cause of death and disability, although studies show that 90% of strokes can be prevented.
Cardiac Rhythm News- 6th September 2018
Get the latest updates from the Cardiac Rhythm news here.
Cardiac rhythm News 24 August 2018
Here you can see all the latest news in one click.
Four out of 10 patients with atrial fibrillation have unknown brain damage
Four out of ten patients with atrial fibrillation but no history of stroke or transient ischaemic attack have previously unknown brain damage, according to the first results of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF) presented today at ESC Congress 2018.